mpharm template submission - general pharmaceutical web viewindependent prescribing submission...

Accreditation of an independent prescribing programme: submission template (parts 1 & 2) This template should be used to demonstrate how the provider meets the GPhC’s accreditation criteria for education and training programmes to train pharmacists as independent prescribers.

The accreditation submission document should be a single document which includes: This template, completed in full, to include:

- A narrative explaining how each criterion is met. The narrative must be written in prose, clearly explaining how the criteria will be met. Reference to links, file names, or module titles on their own are not acceptable.

- Full reference to the documents you are providing as evidence. Any other pertinent information.

You should provide documentary evidence to support the information that you have provided within the template. Following review of your submission document and associated evidence you may be required to submit additional items of evidence, if this is necessary you will be notified in advance of your accreditation event.

The process for reaccreditation of an independent prescribing programme (full or conversion) will follow the same format as described for accreditation. The submission documentation must include, additionally, an introduction section which includes the following:

An overview of how the programme has developed since initial accreditation, including a summary of any major changes

Information on the number of cohorts of the programme that have been delivered since the last event, including the number of pharmacists per cohort.

A summary of the response to any conditions and recommendations that were made by the accreditation team at the previous event. Where a provider opted not to action a recommendation, an explanation of the rationale for this decision should be provided.

Please ensure that you refer to the guidance within this template as failure to provide your submission in the correct format, with the required level of detail and clarity, could lead to your accreditation event being cancelled or postponed. Information on how to submit your documentation can be found on the last page of this document.

If you have any questions regarding your accreditation submission please contact the GPhC’s Quality Assurance (Education) team at [email protected].

mailto:[email protected]

Academic year: 2016-17

Name of University:

Name of School and Department:

Contact name:

Job title:

Address:

Telephone:

Mobile:

Email:

Independent prescribing submission template - for events in the 2016-17 academic year

2

Important – please read the guidance below before completing the template

General notes regarding completion of the template

Except where single pieces of information or lists are asked for, your commentary must be written in prose. Directions to other documents only will not be accepted.

Supporting documents should be included as an appendix to the application template. Hyperlinks may be used within your commentary to signpost to evidence but please check that

the links are not broken and that external access is permitted. Please ensure that all documentary evidence provided is referred to within your commentary. Any diagrams or images should be submitted as documentary evidence and not embedded with

the tables.

Referencing additional materials

For ease of reference, all supporting material should be numbered and named appropriately (for example, Appendix One – Student Handbook, Appendix Two – Programme Specification)

Please ensure the same document name is used throughout the submission and in the appendices.

When referencing supporting material within the submission, please indicate the document clearly (for example, in bold) and use the full name and appendix number throughout.

Applying for reaccreditation of both an independent prescribing programme and independent prescribing conversion programme

If you are applying for reaccreditation of these two programmes to be reviewed as a joint event, you will need to submit a separate submission for each programme but you do not need to repeat your commentary.

We would advise that you complete the submission template for the independent prescribing programme in full first. Only information that is additional or different for the conversion programme needs to be entered into this template. Refer to the full IP template for any instances where the information is the same for both programmes.


3

Submission template part 1: meeting the accreditation criteria

For reaccreditation only

Introduction for reaccreditation

Provider’s commentary:xx

Include:• An overview of how the programme has developed since initial accreditation, including a summary of

any major changes• Information on the number of cohorts of the programme that have been delivered since the last event,

including the number of pharmacists per cohort.• A summary of the response to any conditions and recommendations that were made by the

accreditation team at the previous event. Where a provider opted not to action a recommendation, an explanation of the rationale for this decision should be provided.

(Please delete the guidance notes when completing commentaries and expand as necessary)

Accreditation team’s commentary: For accreditation team use only

Accreditation criteria

Section 1: The programme provider

1.1 Must be part of, or be closely associated with, a higher education institution which implements effective quality assurance and quality management and enhancement systems and demonstrates their application to prescribing programmes. The programme must be validated by its higher education institution.


Include:• Institution• Nature of institution, any affiliations relevant to the application• Department(s) offering the programme• Experience of programme provision relevant to the application• A statement that the institution has fully validated the programme in advance of the application.• Details of quality assurance procedures for example student feedback and input from external examiner


Accreditation team’s commentary: For accreditation team use onlyIndependent prescribing submission template - for events in the 2016-17 academic year

4

(These sections will form part of the record of the event please leave blank and do not delete)

1.2 Must have adequate physical, staff (academic and administrative) and financial resources to deliver the programme including facilities to teach clinical examination skills.


Include:• Accommodation allocated to/used by the programme (include explicit mention of facilities for teaching

clinical examination skills)• Equipment• Support service• Planned student numbers (and maximum student numbers (including ratio of pharmacists to other

health professionals, where applicable)• How the programme will be funded



1.3 Must have identified staff with appropriate background and experience to teach the programme, ideally including practising pharmacists with teaching experience and staff with clinical and diagnostic skills.


Include:• Details of each member of staff associated with the programme (include

names/titles/qualifications/professional affiliations/contribution(s) to the programme/employment status (institutional employee/external)

• Calculate WTE/FTE assigned to programme• Provide Curricula Vitae for each member of staff associated with the programme (summary format is

acceptable)



1.4 Must have an identified practising pharmacist with appropriate background and expertise who will contribute to the design and delivery of the programme. The identified pharmacist must be registered with the General Pharmaceutical Council (GPhC), and where possible should be a pharmacist independent prescriber.



5

Include:• Evidence of how this person(s) has/have contributed to the design of the programme and will contribute

to its delivery.



Section 2: Pre-requisites for entry

2.1 Entrants must be a registered pharmacist with the GPhC or the Pharmaceutical Society of Northern Ireland (PSNI).


Include:• Documentation to demonstrate how you ensure that applicants are suitable for entry to the programme

(e.g. copy of the programme application form).• A description of how this will be checked.



2.2 Entrants must have at least two years appropriate patient-orientated experience in a UK hospital, community or primary care setting following their preregistration year.


Include:• A description of how this will be checked (for both employed and self-employed pharmacists, if

applicable).



2.3 Entrants must have identified an area of clinical practice in which to develop their prescribing skills and have up-to-date clinical, pharmacological and pharmaceutical knowledge relevant to their intended area of prescribing practice.



6

Include:• A description of how this will be established and agreed (for both employed and self-employed

pharmacists, if applicable).



2.4 Entrants should demonstrate how they reflect on their own performance and take responsibility for own CPD.


Include:• An explanation of how this will be demonstrated on application and its role in the programme.



2.5 The provider must ensure that the DMP, identified by the pharmacist, has training and experience appropriate to their role. This may be demonstrated by adherence to the Department of Health Guidance (2001). The DMP must have agreed to provide supervision, support and shadowing opportunities for the student, and be familiar with the GPhC’s requirements of the programme and the need to achieve the learning outcomes.


Include:• An explanation of how experience will be established and validated• Details on training for DMPs• How the DMP’s service level is agreed• A description of how DMPs become familiar with the programme and how the DMP is made aware of

the GPhC requirements and learning outcomes



2.6 Entrants who are not registrants of the GPhC or PSNI may undertake the taught components of the programme but may not undertake the period of supervised practice.

Provider’s commentary:x


7

x

Include:• Specify whether these entrants will be allowed to undertake the taught components. If so explain where

this will be stated, preferably with a referenced quote from a programme document.



Section 3: The programme

3.1 Must be taught at least at bachelor’s degree level (FHEQ (2008), level 6 ) and reflect the fact that since June 2002, pharmacists have graduated and practise at master’s degree level (FHEQ (2008), level 7).


Include:• Information on how the programme was benchmarked against the relevant academic level in the FHEQ

(2008).



3.2 Must achieve the 16 learning outcomes listed in the curriculum for independent prescribing which must be mapped against the programme’s learning outcomes and assessments. The programme learning outcomes must be aligned with the relevant level of study.


Include:• Complete submission template part 2.• The learning outcomes in Part 2 should be interpreted at the correct academic level for the programme

(either level 6, level 7 or both). Level 6 and 7 learning outcomes should be differentiated and it should be made clear how assessments test the correct academic levels).



3.3 Must include teaching, learning and support strategies which allow pharmacists to build on their background knowledge and experience and acquire competence in


8

prescribing.


Describe:• The programme’s teaching and learning strategy• Overall learning time (specify the balance between, taught, directed, self-directed and private study)• How students’ background knowledge and experience will be established• How that knowledge and experience will be developed to acquire competence in prescribing

If the programme relies on web-based learning materials the provider should arrange short-term access so that the panel may review the materials before the accreditation event.



3.4 Must provide opportunities for pharmacists to demonstrate how they will apply their learning to the conditions for which they will be prescribing.


Include:• Description of how each student’s learning will be contextualised in their chosen prescribing field and

how they will demonstrate clinical competence.



3.5 Must contain learning activities equivalent to 26 days, normally over a period of three to six months.


Include:• Describe and quantify the learning activities equivalent to 26 days and confirm the period of delivery.• Proposed timetable for pharmacists undertaking the programme.



3.6 Must have robust systems to monitor attendance and progression.


9


Include:• Description of attendance and progression systems.



3.7 Must have a clear policy on attendance and participation and the obligations of pharmacists who miss part of the programme. Pharmacists must attend all scheduled teaching and learning sessions that provide instruction on clinical examination and diagnosis.


Include:• The programme policy on attendance and the requirements on pharmacists who miss parts of the

programme.• Confirmation that pharmacists must attend all clinical sessions and that they will not pass the

programme if they do not.• How students are made aware of the policy.



3.8 May recognise and allow reduced learning time for previous learning or experience, which is directly equivalent to programme content and for which evidence is provided. Recognition should be according to established institutional procedures on previous learning or experience. Regardless of previous learning or experience, all pharmacists must undertake all assessments.


Include:• Describe arrangements for recognition of previous learning which enable reduction in learning time, if in

existence.• Confirm that pharmacists must undertake all assessments.• Include how students are made aware of the policy.




10

Section 4: Learning in Practice

4.1 The provider must support the DMP with clear and practical guidance on helping the pharmacist successfully to complete the period of learning in practice including arrangements for quality assurance of summative assessments. The roles of the programme provider and the DMP for teaching the skills for clinical assessment of patients must be clearly set out.


Include:• Guidance issued to DMPs relating to successfully completing the period of learning in practice.• Arrangements for the quality assurance of summative assessments of learning in practice.• The roles of the programme provider and DMP for teaching clinical assessment skill.



4.2 The provider must support the DMP with clear and practical guidance on their role in the assessment of the student.


Include:• Description of how DMPs are supported in the assessment students, providing a copy of any relevant

documentation.



4.3 The provider must obtain formal evidence and confirmation from the DMP using the specified wording; “the pharmacist has satisfactorily completed at least 12x7.5h days supervised practice”.


Include:• Description of the nature of the formal evidence from DMPs that pharmacist students have completed

at least 12x7.5h days supervised practice and how the relevant wording will be obtained.• The exact wording from the criterion must be used.


11



4.4 The provider must obtain a professional declaration from the DMP using the specified wording; “In my opinion as the DMP, the skills demonstrated in practice confirm the pharmacist as being suitable for annotation as an Independent Prescriber”’


Include:• Description and evidence of how the relevant wording will be obtained.• The exact wording from the criterion must be used.



4.5 Failure in the period of learning in practice cannot be compensated by performance in other assessments.


Include:• Confirmation that this is the case• Description of where and how students will be made aware of this.



Section 5: Assessment

5.1 Evidence from a range of assessments that the student has achieved the intended learning outcomes of the programme.


Include:• Description of what range of assessments will be used and how that range will test learning outcomes

securely.



12


5.2 The programme will be assessed separately from any other programmes or programme components and lead to a freestanding award which confirms the competence of the pharmacists as an independent prescriber.


Include:• Confirmation of this and explain how relevant assessments will be run separately if parts of the

programme are shared.



5.3 The assessment scheme should demonstrate that the criteria for pass/fail and any arrangements for compensation between elements of assessment, together with the regulations for resit assessments and submissions, are consistent with safe and effective prescribing and the achievement of all learning outcomes.


Include:• Compensation arrangements (see 4.5)• Resit regulations (which must be demonstrably consistent with safe and effective prescribing)• Mechanisms in place to ensure assessments are valid, reliable and robust• A copy of the assessment marking criteria and explain how this is consistent with safe and effective

practice.



5.4 In any assessment, a failure to identify a serious problem or an answer which would cause the patient harm should result in overall failure of the programme.


Include:• Confirmation of this and mechanisms for identifying such problems/answers.• Explanation of how students are made aware of this.



13


Section 6: Details of award

6.1 The provider should award successful candidates a ‘Practice Certificate in Independent Prescribing’ confirming that the candidate has successfully completed the programme and the period of learning in practice.


Include:• Confirmation that this will be the case and provide a sample certificate.



6.2 The provider should send a certified copy of the pass list to the Registrar of the GPhC, via the Applications Team, containing the names and registration numbers of the pharmacists who have successfully completed the programme and confirming that they are eligible for annotation on the GPhC Register as independent prescribers.


Describe:• How the pass list will be certified.• How the pass list will be sent to the General Pharmaceutical Council.• The name and job title of individual responsible for submitting pass lists to the GPhC.




14

Submission template part 2: mapping of independent prescribing learning outcomes to programme learning outcomes and assessments

Level of Study (eg level 6 / level 7)

Note: If the programme is offered at both bachelor’s degree level (FHEQ level 6) and master’s level (FHEQ level 7) please complete a separate mapping table for each including a list of the appropriate learning outcomes for that level.

Learning outcomes

General Pharmaceutical Council (GPhC) Learning Outcomes

Programme Learning Outcomes Assessments

Following qualification, Pharmacist Independent Prescribers will be able to:

Translate the GPhC’s learning outcomes into programme learning outcomes at the relevant FHEQ level.

Describe how each programme learning outcome will be assessed.

1. Understand the responsibility that the role of independent prescriber entails, be aware of their own limitations and work within the limits of their professional competence – knowing when and how to refer / consult / seek guidance from another member of the health care team.

Provider’s commentary:

xx(expand as necessary)

Provider’s commentary:

xx(expand as necessary)

2. Develop an effective relationship and communication with patients, carers, other prescribers and members of the health care team.

3. Describe the pathophysiology of the condition being treated and recognise the signs and symptoms of illness, take an accurate history and carry out a relevant clinical assessment where necessary.

Independent prescribing submission template - for events in the 2016-17 academic year 15

4. Use common diagnostic aids e.g. stethoscope, sphygmomanometer

5. Able to use diagnostic aids relevant to the condition(s) for which the pharmacist intends to prescribe, including monitoring response to therapy.

6. Apply clinical assessment skills to:

inform a working diagnosis formulate a treatment plan for the prescribing of

one or more medicines, if appropriate carry out a checking process to ensure patient

safety monitor response to therapy, review the working differential diagnosis and

modify treatment or refer

consult/seek guidance as appropriate

7. Demonstrate a shared approach to decision making by assessing patients’ needs for medicines, taking account of their wishes and values and those of their carers when making prescribing decisions

8. Identify and assess sources of information, advice and decision support and demonstrate how they will use them in patient care taking into account evidence based practice and national/local guidelines where they exist.

9. Recognise, evaluate and respond to influences on prescribing practice at individual, local and national levels.

10.Prescribe, safely, appropriately and cost effectively.


11.Work within a prescribing partnership.

12.Maintain accurate, effective and timely records and ensure that other prescribers and health care staff are appropriately informed.

13.Demonstrate an understanding of the public health issues related to medicines use.

14.Demonstrate an understanding of the legal, ethical and professional framework for accountability and responsibility in relation to prescribing.

15.Work within clinical governance frameworks that include audit of prescribing practice and personal development.

16.Participate regularly in CPD and maintain a record of their CPD activity

Assessment summary

Assessment method Pass mark Weighting

(Expand table as necessary)


Total 100%


Documentary evidence

List below the documentary evidence that you are providing

Note: You do not need to duplicate evidence - you may find that you need to refer to one piece of documentary

evidence multiple times across more than one section. Please give each piece of evidence a clear and meaningful title. Use the same title when referring to the

evidence within your commentary. Each item listed should be referred to within your commentary.

(expand table as necessary)


19

Submitting your accreditation documentation to the GPhC

You must send the following by post:

4 hard copies of your submission document.Each copy should be bound (No box files, ring binders or lever arch files)NB. Supporting evidence is required electronically only as outlined below

4 USB memory sticks each containing: - A Word and a .PDF version of your submission document - A .PDF version of each item of documentary evidence

Quality Assurance (Education) team General Pharmaceutical Council 25 Canada Square London E14 5LQ

Delivery instructions: Please instruct the courier to deliver the documentation/package to the courier loading bay (deliveries will not be accepted at the main reception building)

Please ensure that the hard copies and electronic copies arrive with the GPhC’s Quality Assurance (Education) Team on, or before, the submission deadline. The deadline for submission of documentation is normally six weeks in advance of the accreditation visit; however, you will be notified of your exact deadline date when we confirm the date of your accreditation visit and pre-visit meeting.


20

mpharm template submission - general pharmaceutical web viewindependent prescribing submission...

Documents